Brief: ContraFect Announces Proposed Public Offering Of Common Stock And Warrants
21/05/2020 21:35
May 21 (Reuters) - ContraFect Corp CFRX.O :
* CONTRAFECT CORPORATION ANNOUNCES PROPOSED PUBLIC OFFERING
OF
COMMON STOCK AND WARRANTS
* CONTRAFECT CORP - INTENDS TO USE NET PROCEEDS OF PUBLIC
OFFERING
TO CONTINUE FUNDING ITS PHASE 3 DISRUPT TRIAL OF EXEBACASE
(CF-301) IN STAPH AUREUS BACTEREMIA
* CONTRAFECT CORP - INTENDS TO USE NET PROCEEDS OF PUBLIC
OFFERING
TO ALSO FUND ADVANCEMENT OF ITS PORTFOLIO, INCLUDING
IND-ENABLING ACTIVITIES FOR CF-370
Source text for Eikon: ID:nGNXbX3ZBK
Further company coverage: CFRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CONTRAFECT
See all newsBrief: Contrafect Corp - On Nov 7, Co Received Delisting Notification From Nasdaq Hearings Advisor Stating That Panel Determined To Delist Co's Common Stock
Brief: ContraFect Says Selling Securityholder May Offer And Selling Up To 7 Mln Shares In Aggregate Of Common Stock
Brief: Contrafect Announces FDA Clearance Of CF-370 IND Application To Proceed With Phase 1 Clinical Study
Brief: Contrafect Corp Says On Sept 21, Notified By Nasdaq, That Co Not In Compliance With The Minimum Bid Price Requirement
Brief: Contrafect Announces Submission Of Ind Application To The FDA For Its Development Candidate Cf-370